Baltimore Ravens Halt Maxx Crosby Trade Over Medical Evaluation Concerns

The Baltimore Ravens have reportedly rescinded their intent to acquire star edge rusher Maxx Crosby from the Las Vegas Raiders, effectively scuttling a high-profile transaction aimed at enhancing both franchises. The Raiders had reportedly sought to leverage Crosby in a trade to accumulate additional NFL Draft capital, aligning with their strategic objectives to bolster team performance.

Eric DeCosta, General Manager for the Ravens, confirmed the decision, attributing the withdrawal to issues that surfaced during the team's medical assessment of Crosby. DeCosta conveyed the organization's initial strong desire to add Crosby to their roster but indicated that a subsequent, thorough review of the potential deal led to the conclusion that proceeding was not advisable.

"A critical step in our process involves bringing a player in to gather comprehensive information," DeCosta stated. "While we undertook this process, our evaluation of the situation ultimately prevented us from finalizing the acquisition." He underscored the gravity of the decision, describing it as a difficult one, though ultimately necessary for the franchise. DeCosta expressed personal disappointment, admitting to being "gutted by it" and calling it a "big regret," but affirmed that his primary allegiance was to the team's welfare. "Nobody's more upset about this than me," he added, emphasizing the professional duty to act in the club's best interest.

The core of the Ravens' apprehension appears to be linked to a knee injury Crosby sustained during the 2025 NFL season. Despite playing through several games, he was ultimately sidelined in Week 15 following a defeat against Philadelphia. Crosby underwent meniscus repair surgery in January 2026, with an anticipated recovery period of three to four months. The collapse of this trade, therefore, suggests that his rehabilitation may not be progressing as favorably as initially hoped, leading the Ravens to question his projected return to full, dependable form.

In a related development, the Ravens have already finalized a significant acquisition, securing Trey Hendrickson, formerly of the Cincinnati Bengals, in a deal valued at $112 million. The initial strategy for Baltimore had been to integrate both Crosby and Hendrickson into their defensive lineup, a plan now altered by the recent development. Observers speculate that the Ravens' ultimate decision signals a final assessment that Crosby may not fully return to a state where the team feels confident in his consistent performance.

The Baltimore Ravens' decision regarding Maxx Crosby is definitive, reshaping both teams' immediate strategies and underscoring the critical role of player health in professional sports transactions.